 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

SQZ Biotechnologies (NYSE:SQZ Free Report) and Beam Therapeutics (NASDAQ:BEAM Free Report) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, analyst recommendations, valuation, dividends, risk, profitability and ...

Head-To-Head Analysis: SQZ Biotechnologies (NYSE:SQZ) and Beam Therapeutics (NASDAQ:BEAM)

SQZ Biotechnologies to be delisted from the NYSE

Shares of SQZ Biotechnologies (NYSE:SQZ Free Report) are set to reverse split before the market opens on Friday, July 7th. The 1-10 reverse split was announced on Friday, July 7th. The number of shares owned by shareholders will be adjusted after the closing bell on Friday, July 7th. SQZ ...

SQZ Biotechnologies (NYSE:SQZ) Shares Set to Reverse Split on Friday, July 7th

InvestorPlace - Stock Market News, Stock Advice & Trading Tips
It's time to start off the week right with a breakdown of the biggest pre-market stock movers worth watching on Monday morning!
The post Todays Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday appeared first on ...

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

SQZ Biotechnologies (NYSE:SQZ  Get Rating) shares are scheduled to reverse split on Friday, July 7th. The 1-10 reverse split was announced on Friday, July 7th. The number of shares owned by shareholders will be adjusted after the market closes on Friday, July 7th. SQZ Biotechnologies Stock ...

SQZ Biotechnologies (NYSE:SQZ) Shares Scheduled to Reverse Split on Friday, July 7th

SQZ Biotechnologies to effect 1-for-10 reverse stock split

SQZ Biotechnologies Company (NYSE: SQZ) (the Company or SQZ), focused on unlocking the full potential of cell therapies, today announced that its Board of Directors (the Board) has approved a 1-for-10 reverse stock split ('reverse split') of its common stock, par value $0.001 per share...

SQZ Biotechnologies to Consolidate Shares with 1-for-10 Reverse Stock Split

Innate Pharma (NASDAQ:IPHA  Get Rating) and SQZ Biotechnologies (NYSE:SQZ  Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, profitability, institutional ownership, ...

SQZ Biotechnologies (NYSE:SQZ) & Innate Pharma (NASDAQ:IPHA) Head to Head Comparison

SQZ Biotechnologies (NYSE:SQZ Get Rating) Investment analysts at HC Wainwright cut their Q2 2023 EPS estimates for shares of SQZ Biotechnologies in a report issued on Thursday, May 11th. HC Wainwright analyst E. Bodnar now anticipates that the company will post earnings of ($0.54) per share for the ...

Q2 2023 EPS Estimates for SQZ Biotechnologies (NYSE:SQZ) Decreased by HC Wainwright

SQZ Biotechnologies (NYSE:SQZ  Get Rating)  Equities researchers at Brookline Capital Management lifted their Q2 2023 EPS estimates for SQZ Biotechnologies in a research note issued to investors on Wednesday, May 10th. Brookline Capital Management analyst L. Cann now forecasts that the...

SQZ Biotechnologies to Post Q2 2023 Earnings of ($0.66) Per Share, Brookline Capital Management Forecasts (NYSE:SQZ)

SQZ Biotechnologies Co. is a clinical-stage biotechnology company, which engages in developing cell therapies for patients with cancer, infectious diseases, and other serious conditions. It operates through SQZ cell therapy platform, which uses membrane disruption to deliver material into cells. The company was founded by Robert S. Langer Jr., Klavis F. Jensen, Agustin Lopez Marquez, and Armon Sharei in March 2013 and is headquartered in Watertown, MA.

Watchers	4
52-Wk Low	$0.0101
52-Wk High	$23.10

Market Cap	$545,586.00
Volume (M)	146,137.00
52-Wk High	$23.10
52-Wk Low	$0.0101

SQZ SQZ Biotechnologies Co

About

Feed

News

Fundamentals